Search research articles
Contact Us
Filters
Showing results (741-750 of 779) with videos related to
Page
of 78
Sort By:
Nature Genetics
|
June 23, 2014
The genomic landscape of nasopharyngeal carcinoma
De-Chen Lin, Xuan Meng, Masaharu Hazawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer
Sandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Translational Lung Cancer Research
|
August 25, 2021
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
Yusuke Sato, Satoshi Watanabe, Takeshi Ota, et al.
Immunotherapy
|
May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab
Satoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Frontiers in Oncology
|
October 11, 2021
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody <i>via</i> Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
Toshiya Fujisaki, Satoshi Watanabe, Takeshi Ota, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Nature Genetics
|
June 26, 2013
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, et al.
Nature Communications
|
July 4, 2015
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
Masafumi Seki, Riki Nishimura, Kenichi Yoshida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2020
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
Goro Nakayama, Nao Takano, Hiroya Taniguchi, et al.
The New England Journal of Medicine
|
July 2, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
Tetsuichi Yoshizato, Bogdan Dumitriu, Kohei Hosokawa, et al.
Page
of 78
Search research articles
Search
Showing results (741-750 of 779) with videos related to
Sort By:
Page
of 78
Nature Genetics
|
June 23, 2014
The genomic landscape of nasopharyngeal carcinoma
De-Chen Lin, Xuan Meng, Masaharu Hazawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer
Sandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Translational Lung Cancer Research
|
August 25, 2021
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
Yusuke Sato, Satoshi Watanabe, Takeshi Ota, et al.
Immunotherapy
|
May 16, 2023
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab
Satoru Taguchi, Taketo Kawai, Sebastiano Buti, et al.
Frontiers in Oncology
|
October 11, 2021
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody <i>via</i> Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
Toshiya Fujisaki, Satoshi Watanabe, Takeshi Ota, et al.
European Urology Focus
|
July 30, 2017
Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Brandon John Manley, Emily C Zabor, Jozefina Casuscelli, et al.
Nature Genetics
|
June 26, 2013
Integrated molecular analysis of clear-cell renal cell carcinoma
Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, et al.
Nature Communications
|
July 4, 2015
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
Masafumi Seki, Riki Nishimura, Kenichi Yoshida, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2020
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
Goro Nakayama, Nao Takano, Hiroya Taniguchi, et al.
The New England Journal of Medicine
|
July 2, 2015
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
Tetsuichi Yoshizato, Bogdan Dumitriu, Kohei Hosokawa, et al.
Page
of 78